The GLP-1 and injectable medications (such as Ozempic) usage and attitudes study is for companies seeking a strategic view of the impact of GLP-1 medications.
To learn more about the study, fill out the form below
A holistic look into GLP-1 and how shoppers are responding to the latest pharma innovation.
Data will be fielded throughout the year with insights available quarterly.
WHAT YOU WILL LEARN
HOW YOU USE IT
THE DETAILS YOU NEED
Who uses GLP-1 medications? How is their lifestyle evolving?
What is the impact on the Food and Beverage industries?
How much to GLP-1s change shopping patterns as far as where and what they eat?
Comprehend this rapidly evolving space by understanding the demographics and attitudes of users
Understand user' needs for products, innovation, and experience at retail
Get preparedfor major shifts due to the rapid adoption of this new drug
Robust sample: 500 shoppers
75+ page report withactionable insights
Fully sliceablecomplete databook for each wave
Customize the study to meet your needs: add search analytics, future-planning, and GTM scenarios
Become a VIP to adapt the study to fit your business needs
With a VIP partnership, you can make sure the study will yield answers to your burning questions about shoppers and how they are reacting to and using GLP-1 medications.
Answering your most pressing questions related to shopper commerce.
Leigh O'Donnell
Head of Shopper and Category Insights & Solutions
Mary Brett Whitfield
Senior Vice President Shopper Insights
Julie Craig
Vice President Shopper Insights
Renata de Moura
Senior Director Shopper Insights
Looking for insights?
Take a look at content catered to you.
Retail Sound Bites
The Kantar Sound Bites podcast provides a provocative view of global retail trends, category leadership, business issues, and other shopper and retail related news.
Kantar’s annual industry benchmarking report identifies retailers and suppliers that set the standard of performance, ranked by their trading partners.
